-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: BIOtechNOW Editor
BioManufacturers Increasing Budgets for New Technologies
By Eric Langer, Managing Partner, BioPlan Associates, Inc. Two-thirds Spending more for Improved Productivity Almost two-thirds (64.2 percent) of biomanufacturers will increase their budgets for new technologies to improve efficiencies and costs for downstream production this year. Data from our newly released 9th Annual Report and Survey of Biopharmaceutical Manufacturers, include responses from 302 global biomanufacturers, and an additional 185 vendors to the industry. We find that budget increases this year are not just incremental Read More >
Biotech Patent Case Law Updates at the IPCC
By John W. Cox, Counsel at Alston+Bird LLP The Spring 2012 BIO Intellectual Property Counsels’ Committee (IPCC) Conference, held in Austin, Texas, provided an excellent forum for intellectual property (IP) practitioners in the biotech industry to socialize, network, and participate in panel discussions focusing on the dynamic developments in the patent laws. The conference began for the general participants over margaritas and Tex-Mex fare, where attendees were already discussing recent Supreme Court and Federal Circuit decisions Read More >
The Life Sciences Foundation – Telling the Story of Biotechnology
By the Life Sciences Foundation “If a man were permitted to make all the ballads, he need not care who should make the laws of a nation.” – Scottish politician Andrew Fletcher (1653-1716) Why History Matters Biotechnologists are in the tomorrow business. They strive to innovate, invent, and make progress. They must; survival depends on it. Biotechnologists are future-oriented. Yet, biotechnologists are also steeped in history. They swim in the past, and strive constantly to Read More >
Fox Trial Finder and You: Use It to Recruit for Your Trials or to Get Involved Yourself!
From The Michael J. Fox Foundation for Parkinson’s Research The Michael J. Fox Foundation has launched Fox Trial Finder, a new Web tool that uses state-of-the art technology to connect potential study volunteers with the coordinators of clinical studies that need someone with their specific medical history. The goal is to benefit both study sponsors and patients by getting people into clinical trials and studies faster — speeding the development of new treatments and ultimately a Read More >
From Despair to Hope, a New World of Treatments
By David Welch, President and Senior Producer, M2 MultiMedia Communications Tonight, Wednesday March 28 at 9:00 EST, a documentary called From Despair to Hope, A New World of Treatments, will be broadcast on WUSA-TV, the CBS affiliate in Washington, D.C. It is sponsored by the Biotechnology Industry Organization. For me, producing this program was a yet another profound reminder of the contributions of biotechnology companies that are helping millions of patients throughout the world live hopeful Read More >
